Literature DB >> 710836

Cell proliferation in esophageal columnar epithelium (Barrett's esophagus).

J J Herbst, M M Berenson, D W McCloskey, W C Wiser.   

Abstract

In order to correlate histopathology and cell turnover in esophageal tissue in patients with esophageal columnar epithelium, biopsy specimens from 11 patients were studied. Two of the patients had adenocarcinoma of the esophagus not present in the specimens studied. In the heterogeneous esophageal columnar epithelium, the DNA synthesis phase averaged 10.4 +/- 0.3 hr; labeling index of cells in the crypt-like structures was 23.3 +/- 0.3%; generation time was 44.6 +/- 1.2 hr, and the mitotic index was 1.82 +/- 0.07%. Significant differences were not present among specimens with columnar epithelium but they differed from cell proliferation in adjacent squamous epithelium where S phase was similar but labeling and mitotic indexes were lower and generation time increased to 105 +/- 6 hr. In the 2 patients with adenocarcinoma of the esophagus, and in 1 of 9 without adenocarcinoma, labeling of surface columnar cells after brief exposure to [3H]thymidine was present suggests that this may be a manifestation of early malignant change.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 710836

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

Review 1.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues.

Authors:  James R Kraly; Megan R Jones; David G Gomez; Jane A Dickerson; Melissa M Harwood; Michael Eggertson; Thomas G Paulson; Carissa A Sanchez; Robert Odze; Ziding Feng; Brian J Reid; Norman J Dovichi
Journal:  Anal Chem       Date:  2006-09-01       Impact factor: 6.986

3.  Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.

Authors:  Pierre Lao-Sirieix; Rebecca Brais; Laurence Lovat; Nicholas Coleman; Rebecca C Fitzgerald
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

4.  Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus.

Authors:  S Y Iftikhar; R J Steele; S Watson; P D James; K Dilks; J D Hardcastle
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

5.  The effect of reactive atypia/inflammation on the laser-induced fluorescence diagnosis of non-dysplastic Barrett's esophagus.

Authors:  Masoud Panjehpour; Bergein F Overholt; Tuan Vo-Dinh; Domenico Coppola
Journal:  Lasers Surg Med       Date:  2012-04-25       Impact factor: 4.025

Review 6.  How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus.

Authors:  Philippe G Guillem
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

7.  Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markers.

Authors:  F T Peters; S Ganesh; E J Kuipers; A de Jager-Krikken; A Karrenbeld; G Harms; W J Sluiter; J Koudstaal; E C Klinkenberg-Knol; C B Lamers; J H Kleibeuker
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

8.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

9.  Dysplasia in Barrett's esophagus.

Authors:  H G Schmidt; R H Riddell; B Walther; D B Skinner; J F Riemann
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

10.  Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

Authors:  Dennis L Chao; Carissa A Sanchez; Patricia C Galipeau; Patricia L Blount; Thomas G Paulson; David S Cowan; Kamran Ayub; Robert D Odze; Peter S Rabinovitch; Brian J Reid
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.